Make Gene Delivery Accessible
Side-by-Side Navigation for Your Innovations
Industrialize Your Product at OBiO – End-to-End Offerings with Versatile Technical Platform
Explore Our SolutionsThis page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Side-by-Side Navigation for Your Innovations
Industrialize Your Product at OBiO – End-to-End Offerings with Versatile Technical Platform
Explore Our SolutionsEstablished in 2013, OBiO Technology (Shanghai) Corp., Ltd. (Stock: 688238) is a pioneering Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy. Guided by our mission “Enable Cell and Gene Therapy for Better Lives”, we deliver top-tier services globally.
We integrate resources to serve life sciences, focusing on three core directions: basic CRO, CDMO in cell and gene therapy, and Regenerative Medicine (Life&Health CDMO). Our values — Customer Focus, Efficient Execution, Excellence, Innovation, and Integrity — drive every OBiOer.
Providing client-centered and high-quality service as our commitment, we strive to become a world-leading gene and cell therapy CRO/CDMO group.
We align our goals with yours, ensuring your innovation is supported at every stage — from bench to clinic.
Our GMP-compliant processes and rigorous quality control ensure safety, consistency, and regulatory readiness.
By 2023, we helped clients secure 25 IND approvals — including 8 from the FDA — accelerating therapies worldwide.
OBiO offers holistic solutions in process development, analytical methods, IND-enabling CMC, and clinical/commercial manufacturing of viral vectors, oncolytic viruses, and cell therapy products.
End-to-end contract development and manufacturing for viral vectors, oncolytic viruses, and cell therapies — from preclinical to commercial scale.
Integrated portfolio of services for biomedical researchers, including plasmid construction, viral packaging, and in vivo studies.
OBiO provides off-the-shelf tools and custom solutions to accelerate your research in gene and cell therapy.
Ready-to-use AAV vectors for neuroscience, cardiovascular, and oncology research.
High-purity plasmid DNA construction and GMP-grade production.
AAVneO® vector screening for novel, tissue-specific capsids.
Genome-wide and pathway-specific CRISPR screening libraries.
High-expression, clonal cell lines for bioproduction and research.
Multiple serotypes available for gene delivery in vivo and in vitro.
High-titer lentiviral vectors for stable gene expression.
Synthetic RNA molecules for gene silencing and functional studies.
High-capacity adenoviral vectors for vaccine and gene therapy applications.
Replication-defective retroviral vectors for ex vivo gene transfer.
Neurotropic HSV vectors for neuroscience and oncolytic therapy.
Custom cell preparation, storage, and exosome production services.
State-of-the-art GMP and R&D facilities across China and the U.S., supporting innovation from discovery to commercialization.
Integrated Laboratory Services and Process Development Center in Shanghai.
Three-building, 10,000-square-meter campus dedicated to GMP manufacturing.
Commissioned April 21, 2023 — 80,000m² facility for large-scale CGT manufacturing.
Founded in 2022 to expand global business and client support.
FDA Acceptance of Drug Master File – GMP Plasmid Products
June 29, 2023 | March 26, 2025
A major milestone for OBiO’s GMP plasmid platform, enabling faster IND submissions for clients.
How to Choose Precision AAV Tools for Cardiovascular Research?
October 13, 2025
Expert insights on selecting optimal AAV serotypes and promoters for heart disease models.
Ready to accelerate your gene therapy program? Reach out to our team.
Phone: +1 (448) 200-6695
Email: [email protected]
Business: [email protected]
Address:
10410 Corporate Drive, Sugar Land, TX 77478, USA
For project inquiries, regulatory support, or technical consultations, visit our official website.
Visit Official WebsiteNotice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]